<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:08:15Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/11141" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/11141</identifier><datestamp>2026-10-18T21:13:13Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Protective effect of adenosine triphosphate against cisplatin-induced necrotic and degenerative oral mucositis in rats</dc:title><dc:creator>Salcan, Ismail</dc:creator><dc:creator>Dilber, Muhammed</dc:creator><dc:creator>Suleyman, Zeynep</dc:creator><dc:creator>Yucel, Nurinisa</dc:creator><dc:creator>Salcan, Sara</dc:creator><dc:creator>Kesan, Sefa</dc:creator><dc:creator>Yazici, Gulce Naz</dc:creator><dc:creator>Celik, Fatih</dc:creator><dc:creator>Koseturk, Merve</dc:creator><dc:creator>Alp, Nurdan Alcan</dc:creator><dc:creator>Suleyman, Halis</dc:creator><dc:subject>Adenosine triphosphate</dc:subject><dc:subject>Cisplatin</dc:subject><dc:subject>Oxidative injury</dc:subject><dc:subject>Rat</dc:subject><dc:subject>Tongue</dc:subject><dc:subject>Animals</dc:subject><dc:subject>Antineoplastic Agents</dc:subject><dc:subject>Cytokines</dc:subject><dc:subject>Male</dc:subject><dc:subject>Mouth Mucosa</dc:subject><dc:subject>Necrosis</dc:subject><dc:subject>Oxidative Stress</dc:subject><dc:subject>Random Allocation</dc:subject><dc:subject>Rats, Wistar</dc:subject><dc:subject>Reproducibility of Results</dc:subject><dc:subject>Stomatitis</dc:subject><dc:subject>Time Factors</dc:subject><dc:subject>Treatment Outcome</dc:subject><dc:subject>antineoplastic agent</dc:subject><dc:subject>cytokine</dc:subject><dc:subject>animal</dc:subject><dc:subject>drug effect</dc:subject><dc:subject>drug therapy</dc:subject><dc:subject>evaluation study</dc:subject><dc:subject>pathology</dc:subject><dc:subject>prevention and control</dc:subject><dc:subject>randomization</dc:subject><dc:subject>reproducibility</dc:subject><dc:subject>time factor</dc:subject><dc:subject>Wistar rat</dc:subject><dc:description>Inflammation, oxidative damage, and adenosine triphosphate (ATP) depletion play a role in the7 pathogenesis of cisplatin (CIS)-induced oral mucositis. Objective: The purpose of this research is to examine8 the impact of ATP against potential oral mucositis development in cisplatin-treated rats. Methodology All rats9 were randomly assigned to four groups, namely healthy control group (HG), ATP group (ATPG), Cisplatin10 group (CISG), and ATP + Cisplatin group (ATCS). Firstly, ATP 4 mg/kg was administered via intraperitoneal11 injection (IP) to both ATPG and ATCS groups. The same volume of normal saline was injected into HG and12 CISG groups. After 1 h, cisplatin 5 mg/kg was administered via IP to CISG and ATCS groups. The drugs13 were taken 1x1 for 7 d. Later, tongue tissues were collected from all groups. Biochemical, macroscopic,14 and histopathological examinations were performed on all tissues. Results: ATP inhibited cisplatin-induced15 oxidative damage and pro-inflammatory cytokines levels in tongue tissue. In the CIS group, a significant16 number of distinct sulcus formations were found in the apex and corpus, as well as a few ulcer foci in the17 corpus, significant papilla loss, and bleeding. Meanwhile, in the ATP group, a similar appearance to healthy18 tissue was observed. Histopathologically, it was determined that in cisplatin-aggravated tongue tissue19 damage, filiform papillae decreased when ATP was administered, and the arrangement and structures of20 the epithelium, blood capillaries, muscle groups, and adipose cell groups were normal. Conclusions: Oral21 mucositis caused by cisplatin is alleviated by ATP. These findings may be useful for developing new therapeutic22 approaches to prevent or treat mucositis, a side effect so severe that can lead to treatment discontinuation.23 24. © 2025, Faculdade de Odontologia de Bauru da Universidade de Sao Paulo. All rights reserved.</dc:description><dc:publisher>Faculdade de Odontologia de Bauru da Universidade de Sao Paulo</dc:publisher><dc:date>2025</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/11141</dc:identifier><dc:identifier>https://doi.org/10.1590/1678-7757-2025-0007</dc:identifier><dc:identifier>1678-7757</dc:identifier><dc:language>en</dc:language><dc:relation>Journal of Applied Oral Science</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/11141</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>